BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 91 hits with Last Name = 'yoder' and Initial = 'sc'   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kJ/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
Egl nine homolog 1


(Homo sapiens (Human))		BDBM50251959
PNG
(2-(2-(2-(4-tert-butylbenzylsulfonyl)acetamido)-3-h...)
Show SMILES CC(C)(C)c1ccc(CS(=O)(=O)CC(=O)N=c2scc(CC(O)=O)n2O)cc1 |w:15.14|
Show InChI InChI=1S/C18H22N2O6S2/c1-18(2,3)13-6-4-12(5-7-13)10-28(25,26)11-15(21)19-17-20(24)14(9-27-17)8-16(22)23/h4-7,9,24H,8,10-11H2,1-3H3,(H,22,23)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 3n/an/an/an/an/an/a



Amgen, Inc.

Curated by ChEMBL


Assay Description
Inhibition of human PHD2 assesssed as hydroxylation of Pro564 in human HIF-1alpha by TR-FRET assay

Bioorg Med Chem Lett 18: 3925-8 (2008)


Article DOI: 10.1016/j.bmcl.2008.06.031
BindingDB Entry DOI: 10.7270/Q2XW4JM5
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM50264220
PNG
(2-(1,6-diphenyl-1H-imidazo[4,5-c]pyridine-4-carbox...)
Show SMILES OC(=O)CNC(=O)c1nc(cc2n(cnc12)-c1ccccc1)-c1ccccc1
Show InChI InChI=1S/C21H16N4O3/c26-18(27)12-22-21(28)20-19-17(11-16(24-20)14-7-3-1-4-8-14)25(13-23-19)15-9-5-2-6-10-15/h1-11,13H,12H2,(H,22,28)(H,26,27)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 3n/an/an/an/an/an/a



Amgen, Inc.

Curated by ChEMBL


Assay Description
Inhibition of PHD2 (unknown origin) by fluorescence energy transfer analysis

Bioorg Med Chem Lett 18: 5023-6 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.012
BindingDB Entry DOI: 10.7270/Q2ZS2WB7
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93422
PNG
(PHD Inhibitor, 12{1,1,2})
Show SMILES CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C38H37N5O8/c1-22(44)41-30(19-24-12-14-26-10-6-7-11-27(26)16-24)36(49)42-29(18-23-8-4-3-5-9-23)35(48)39-20-25-13-15-31-28(17-25)34(47)33(38(51)43(31)2)37(50)40-21-32(45)46/h3-17,29-30,47H,18-21H2,1-2H3,(H,39,48)(H,40,50)(H,41,44)(H,42,49)(H,45,46)/t29-,30-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 4.30n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93422
PNG
(PHD Inhibitor, 12{1,1,2})
Show SMILES CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C38H37N5O8/c1-22(44)41-30(19-24-12-14-26-10-6-7-11-27(26)16-24)36(49)42-29(18-23-8-4-3-5-9-23)35(48)39-20-25-13-15-31-28(17-25)34(47)33(38(51)43(31)2)37(50)40-21-32(45)46/h3-17,29-30,47H,18-21H2,1-2H3,(H,39,48)(H,40,50)(H,41,44)(H,42,49)(H,45,46)/t29-,30-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 4.5n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93425
PNG
(PHD Inhibitor, 12{4,1,2})
Show SMILES CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)NCC(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C31H31N5O8/c1-17(37)35-23(13-18-7-9-20-5-3-4-6-21(20)11-18)29(42)33-15-25(38)32-14-19-8-10-24-22(12-19)28(41)27(31(44)36(24)2)30(43)34-16-26(39)40/h3-12,23,41H,13-16H2,1-2H3,(H,32,38)(H,33,42)(H,34,43)(H,35,37)(H,39,40)/t23-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 5.10n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93419
PNG
(PHD Inhibitor, 12{2,4,1})
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)c3ccccc3)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C39H37N5O8/c1-44-31-18-17-26(19-28(31)34(47)33(39(44)52)38(51)41-23-32(45)46)22-40-36(49)29(20-24-11-5-2-6-12-24)43-37(50)30(21-25-13-7-3-8-14-25)42-35(48)27-15-9-4-10-16-27/h2-19,29-30,47H,20-23H2,1H3,(H,40,49)(H,41,51)(H,42,48)(H,43,50)(H,45,46)/t29-,30-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 5.30n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93430
PNG
(PHD Inhibitor, 12{2,1,2})
Show SMILES CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C38H37N5O8/c1-22(44)41-30(19-24-12-14-26-10-6-7-11-27(26)16-24)36(49)42-29(18-23-8-4-3-5-9-23)35(48)39-20-25-13-15-31-28(17-25)34(47)33(38(51)43(31)2)37(50)40-21-32(45)46/h3-17,29-30,47H,18-21H2,1-2H3,(H,39,48)(H,40,50)(H,41,44)(H,42,49)(H,45,46)/t29-,30-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 6.40n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93423
PNG
(PHD Inhibitor, 12{2,3,2} | PHD Inhibitor, 12{2,4,2...)
Show SMILES CC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C34H35N5O8/c1-20(40)37-26(17-22-11-7-4-8-12-22)32(45)38-25(16-21-9-5-3-6-10-21)31(44)35-18-23-13-14-27-24(15-23)30(43)29(34(47)39(27)2)33(46)36-19-28(41)42/h3-15,25-26,43H,16-19H2,1-2H3,(H,35,44)(H,36,46)(H,37,40)(H,38,45)(H,41,42)/t25-,26-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 7.20n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93426
PNG
(PHD Inhibitor, 12{2,5,2})
Show SMILES CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C34H35N5O8/c1-20(40)37-26(17-22-11-7-4-8-12-22)32(45)38-25(16-21-9-5-3-6-10-21)31(44)35-18-23-13-14-27-24(15-23)30(43)29(34(47)39(27)2)33(46)36-19-28(41)42/h3-15,25-26,43H,16-19H2,1-2H3,(H,35,44)(H,36,46)(H,37,40)(H,38,45)(H,41,42)/t25-,26+/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 7.60n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93419
PNG
(PHD Inhibitor, 12{2,4,1})
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)c3ccccc3)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C39H37N5O8/c1-44-31-18-17-26(19-28(31)34(47)33(39(44)52)38(51)41-23-32(45)46)22-40-36(49)29(20-24-11-5-2-6-12-24)43-37(50)30(21-25-13-7-3-8-14-25)42-35(48)27-15-9-4-10-16-27/h2-19,29-30,47H,20-23H2,1H3,(H,40,49)(H,41,51)(H,42,48)(H,43,50)(H,45,46)/t29-,30-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 8.5n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93426
PNG
(PHD Inhibitor, 12{2,5,2})
Show SMILES CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C34H35N5O8/c1-20(40)37-26(17-22-11-7-4-8-12-22)32(45)38-25(16-21-9-5-3-6-10-21)31(44)35-18-23-13-14-27-24(15-23)30(43)29(34(47)39(27)2)33(46)36-19-28(41)42/h3-15,25-26,43H,16-19H2,1-2H3,(H,35,44)(H,36,46)(H,37,40)(H,38,45)(H,41,42)/t25-,26+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 8.90n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93427
PNG
(PHD Inhibitor, 12{2,6,2})
Show SMILES CC(C)C[C@H](NC(C)=O)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C31H37N5O8/c1-17(2)12-22(34-18(3)37)29(42)35-23(14-19-8-6-5-7-9-19)28(41)32-15-20-10-11-24-21(13-20)27(40)26(31(44)36(24)4)30(43)33-16-25(38)39/h5-11,13,17,22-23,40H,12,14-16H2,1-4H3,(H,32,41)(H,33,43)(H,34,37)(H,35,42)(H,38,39)/t22-,23+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 11n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM50251958
PNG
(2-(2-(2-(benzylsulfonyl)acetamido)-3-hydroxy-2,3-d...)
Show SMILES OC(=O)Cc1csc(=NC(=O)CS(=O)(=O)Cc2ccccc2)n1O |w:8.8|
Show InChI InChI=1S/C14H14N2O6S2/c17-12(9-24(21,22)8-10-4-2-1-3-5-10)15-14-16(20)11(7-23-14)6-13(18)19/h1-5,7,20H,6,8-9H2,(H,18,19)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 11n/an/an/an/an/an/a



Amgen, Inc.

Curated by ChEMBL


Assay Description
Inhibition of human PHD2 assesssed as hydroxylation of Pro564 in human HIF-1alpha by TR-FRET assay

Bioorg Med Chem Lett 18: 3925-8 (2008)


Article DOI: 10.1016/j.bmcl.2008.06.031
BindingDB Entry DOI: 10.7270/Q2XW4JM5
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93423
PNG
(PHD Inhibitor, 12{2,3,2} | PHD Inhibitor, 12{2,4,2...)
Show SMILES CC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C34H35N5O8/c1-20(40)37-26(17-22-11-7-4-8-12-22)32(45)38-25(16-21-9-5-3-6-10-21)31(44)35-18-23-13-14-27-24(15-23)30(43)29(34(47)39(27)2)33(46)36-19-28(41)42/h3-15,25-26,43H,16-19H2,1-2H3,(H,35,44)(H,36,46)(H,37,40)(H,38,45)(H,41,42)/t25-,26-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 11.7n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93423
PNG
(PHD Inhibitor, 12{2,3,2} | PHD Inhibitor, 12{2,4,2...)
Show SMILES CC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C34H35N5O8/c1-20(40)37-26(17-22-11-7-4-8-12-22)32(45)38-25(16-21-9-5-3-6-10-21)31(44)35-18-23-13-14-27-24(15-23)30(43)29(34(47)39(27)2)33(46)36-19-28(41)42/h3-15,25-26,43H,16-19H2,1-2H3,(H,35,44)(H,36,46)(H,37,40)(H,38,45)(H,41,42)/t25-,26-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 12.2n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93428
PNG
(PHD Inhibitor, 12{2,3,4} | PHD Inhibitor, 12{2,4,4...)
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)C(C)(C)C)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C37H41N5O8/c1-37(2,3)36(50)41-27(19-23-13-9-6-10-14-23)33(47)40-26(18-22-11-7-5-8-12-22)32(46)38-20-24-15-16-28-25(17-24)31(45)30(35(49)42(28)4)34(48)39-21-29(43)44/h5-17,26-27,45H,18-21H2,1-4H3,(H,38,46)(H,39,48)(H,40,47)(H,41,50)(H,43,44)/t26-,27-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 12.6n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93428
PNG
(PHD Inhibitor, 12{2,3,4} | PHD Inhibitor, 12{2,4,4...)
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)C(C)(C)C)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C37H41N5O8/c1-37(2,3)36(50)41-27(19-23-13-9-6-10-14-23)33(47)40-26(18-22-11-7-5-8-12-22)32(46)38-20-24-15-16-28-25(17-24)31(45)30(35(49)42(28)4)34(48)39-21-29(43)44/h5-17,26-27,45H,18-21H2,1-4H3,(H,38,46)(H,39,48)(H,40,47)(H,41,50)(H,43,44)/t26-,27-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 12.9n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93428
PNG
(PHD Inhibitor, 12{2,3,4} | PHD Inhibitor, 12{2,4,4...)
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)C(C)(C)C)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C37H41N5O8/c1-37(2,3)36(50)41-27(19-23-13-9-6-10-14-23)33(47)40-26(18-22-11-7-5-8-12-22)32(46)38-20-24-15-16-28-25(17-24)31(45)30(35(49)42(28)4)34(48)39-21-29(43)44/h5-17,26-27,45H,18-21H2,1-4H3,(H,38,46)(H,39,48)(H,40,47)(H,41,50)(H,43,44)/t26-,27-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 13.2n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93423
PNG
(PHD Inhibitor, 12{2,3,2} | PHD Inhibitor, 12{2,4,2...)
Show SMILES CC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C34H35N5O8/c1-20(40)37-26(17-22-11-7-4-8-12-22)32(45)38-25(16-21-9-5-3-6-10-21)31(44)35-18-23-13-14-27-24(15-23)30(43)29(34(47)39(27)2)33(46)36-19-28(41)42/h3-15,25-26,43H,16-19H2,1-2H3,(H,35,44)(H,36,46)(H,37,40)(H,38,45)(H,41,42)/t25-,26-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 13.5n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93425
PNG
(PHD Inhibitor, 12{4,1,2})
Show SMILES CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)NCC(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C31H31N5O8/c1-17(37)35-23(13-18-7-9-20-5-3-4-6-21(20)11-18)29(42)33-15-25(38)32-14-19-8-10-24-22(12-19)28(41)27(31(44)36(24)2)30(43)34-16-26(39)40/h3-12,23,41H,13-16H2,1-2H3,(H,32,38)(H,33,42)(H,34,43)(H,35,37)(H,39,40)/t23-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 13.5n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93430
PNG
(PHD Inhibitor, 12{2,1,2})
Show SMILES CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C38H37N5O8/c1-22(44)41-30(19-24-12-14-26-10-6-7-11-27(26)16-24)36(49)42-29(18-23-8-4-3-5-9-23)35(48)39-20-25-13-15-31-28(17-25)34(47)33(38(51)43(31)2)37(50)40-21-32(45)46/h3-17,29-30,47H,18-21H2,1-2H3,(H,39,48)(H,40,50)(H,41,44)(H,42,49)(H,45,46)/t29-,30-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 13.5n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93432
PNG
(PHD Inhibitor, 12{2,6,4})
Show SMILES CC(C)C[C@@H](NC(=O)C(C)(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C34H43N5O8/c1-19(2)14-23(38-33(47)34(3,4)5)30(44)37-24(16-20-10-8-7-9-11-20)29(43)35-17-21-12-13-25-22(15-21)28(42)27(32(46)39(25)6)31(45)36-18-26(40)41/h7-13,15,19,23-24,42H,14,16-18H2,1-6H3,(H,35,43)(H,36,45)(H,37,44)(H,38,47)(H,40,41)/t23-,24-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 14.5n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93428
PNG
(PHD Inhibitor, 12{2,3,4} | PHD Inhibitor, 12{2,4,4...)
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)C(C)(C)C)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C37H41N5O8/c1-37(2,3)36(50)41-27(19-23-13-9-6-10-14-23)33(47)40-26(18-22-11-7-5-8-12-22)32(46)38-20-24-15-16-28-25(17-24)31(45)30(35(49)42(28)4)34(48)39-21-29(43)44/h5-17,26-27,45H,18-21H2,1-4H3,(H,38,46)(H,39,48)(H,40,47)(H,41,50)(H,43,44)/t26-,27-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 14.6n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93427
PNG
(PHD Inhibitor, 12{2,6,2})
Show SMILES CC(C)C[C@H](NC(C)=O)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C31H37N5O8/c1-17(2)12-22(34-18(3)37)29(42)35-23(14-19-8-6-5-7-9-19)28(41)32-15-20-10-11-24-21(13-20)27(40)26(31(44)36(24)4)30(43)33-16-25(38)39/h5-11,13,17,22-23,40H,12,14-16H2,1-4H3,(H,32,41)(H,33,43)(H,34,37)(H,35,42)(H,38,39)/t22-,23+/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 16.2n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93432
PNG
(PHD Inhibitor, 12{2,6,4})
Show SMILES CC(C)C[C@@H](NC(=O)C(C)(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C34H43N5O8/c1-19(2)14-23(38-33(47)34(3,4)5)30(44)37-24(16-20-10-8-7-9-11-20)29(43)35-17-21-12-13-25-22(15-21)28(42)27(32(46)39(25)6)31(45)36-18-26(40)41/h7-13,15,19,23-24,42H,14,16-18H2,1-6H3,(H,35,43)(H,36,45)(H,37,44)(H,38,47)(H,40,41)/t23-,24-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 16.8n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93433
PNG
(PHD Inhibitor, 12{2,1,4})
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc4ccccc4c3)NC(=O)C(C)(C)C)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C41H43N5O8/c1-41(2,3)40(54)45-31(21-25-14-16-27-12-8-9-13-28(27)18-25)37(51)44-30(20-24-10-6-5-7-11-24)36(50)42-22-26-15-17-32-29(19-26)35(49)34(39(53)46(32)4)38(52)43-23-33(47)48/h5-19,30-31,49H,20-23H2,1-4H3,(H,42,50)(H,43,52)(H,44,51)(H,45,54)(H,47,48)/t30-,31-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 18.8n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93419
PNG
(PHD Inhibitor, 12{2,4,1})
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)c3ccccc3)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C39H37N5O8/c1-44-31-18-17-26(19-28(31)34(47)33(39(44)52)38(51)41-23-32(45)46)22-40-36(49)29(20-24-11-5-2-6-12-24)43-37(50)30(21-25-13-7-3-8-14-25)42-35(48)27-15-9-4-10-16-27/h2-19,29-30,47H,20-23H2,1H3,(H,40,49)(H,41,51)(H,42,48)(H,43,50)(H,45,46)/t29-,30-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 20n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM50252002
PNG
(2-(2-(2-(4-tert-butylphenylsulfonyl)acetamido)-3-h...)
Show SMILES CC(C)(C)c1ccc(cc1)S(=O)(=O)CC(=O)N=c1scc(CC(O)=O)n1O |w:16.16|
Show InChI InChI=1S/C17H20N2O6S2/c1-17(2,3)11-4-6-13(7-5-11)27(24,25)10-14(20)18-16-19(23)12(9-26-16)8-15(21)22/h4-7,9,23H,8,10H2,1-3H3,(H,21,22)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 21n/an/an/an/an/an/a



Amgen, Inc.

Curated by ChEMBL


Assay Description
Inhibition of human PHD2 assesssed as hydroxylation of Pro564 in human HIF-1alpha by TR-FRET assay

Bioorg Med Chem Lett 18: 3925-8 (2008)


Article DOI: 10.1016/j.bmcl.2008.06.031
BindingDB Entry DOI: 10.7270/Q2XW4JM5
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM50251957
PNG
(CHEMBL519615 | {2-[2-(Biphenyl-4-sulfonyl)-acetyli...)
Show SMILES OC(=O)Cc1csc(=NC(=O)CS(=O)(=O)c2ccc(cc2)-c2ccccc2)n1O |w:8.8|
Show InChI InChI=1S/C19H16N2O6S2/c22-17(20-19-21(25)15(11-28-19)10-18(23)24)12-29(26,27)16-8-6-14(7-9-16)13-4-2-1-3-5-13/h1-9,11,25H,10,12H2,(H,23,24)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 21n/an/an/an/an/an/a



Amgen, Inc.

Curated by ChEMBL


Assay Description
Inhibition of human PHD2 assesssed as hydroxylation of Pro564 in human HIF-1alpha by TR-FRET assay

Bioorg Med Chem Lett 18: 3925-8 (2008)


Article DOI: 10.1016/j.bmcl.2008.06.031
BindingDB Entry DOI: 10.7270/Q2XW4JM5
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93419
PNG
(PHD Inhibitor, 12{2,4,1})
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)c3ccccc3)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C39H37N5O8/c1-44-31-18-17-26(19-28(31)34(47)33(39(44)52)38(51)41-23-32(45)46)22-40-36(49)29(20-24-11-5-2-6-12-24)43-37(50)30(21-25-13-7-3-8-14-25)42-35(48)27-15-9-4-10-16-27/h2-19,29-30,47H,20-23H2,1H3,(H,40,49)(H,41,51)(H,42,48)(H,43,50)(H,45,46)/t29-,30-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 22n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM50251908
PNG
(2-(3-hydroxy-2-(2-(naphthalen-2-ylsulfonyl)acetami...)
Show SMILES OC(=O)Cc1csc(=NC(=O)CS(=O)(=O)c2ccc3ccccc3c2)n1O |w:8.8|
Show InChI InChI=1S/C17H14N2O6S2/c20-15(18-17-19(23)13(9-26-17)8-16(21)22)10-27(24,25)14-6-5-11-3-1-2-4-12(11)7-14/h1-7,9,23H,8,10H2,(H,21,22)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 27n/an/an/an/an/an/a



Amgen, Inc.

Curated by ChEMBL


Assay Description
Inhibition of human PHD2 assesssed as hydroxylation of Pro564 in human HIF-1alpha by TR-FRET assay

Bioorg Med Chem Lett 18: 3925-8 (2008)


Article DOI: 10.1016/j.bmcl.2008.06.031
BindingDB Entry DOI: 10.7270/Q2XW4JM5
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93420
PNG
(PHD Inhibitor, 12{3,1,4})
Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1cccc2ccccc12)NC(=O)C(C)(C)C)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C38H45N5O8/c1-21(2)16-27(41-34(48)28(42-37(51)38(3,4)5)18-24-12-9-11-23-10-7-8-13-25(23)24)33(47)39-19-22-14-15-29-26(17-22)32(46)31(36(50)43(29)6)35(49)40-20-30(44)45/h7-15,17,21,27-28,46H,16,18-20H2,1-6H3,(H,39,47)(H,40,49)(H,41,48)(H,42,51)(H,44,45)/t27-,28-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 32n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM50251907
PNG
(2-(2-(2-(4-chlorophenylsulfonyl)acetamido)-3-hydro...)
Show SMILES OC(=O)Cc1csc(=NC(=O)CS(=O)(=O)c2ccc(Cl)cc2)n1O |w:8.8|
Show InChI InChI=1S/C13H11ClN2O6S2/c14-8-1-3-10(4-2-8)24(21,22)7-11(17)15-13-16(20)9(6-23-13)5-12(18)19/h1-4,6,20H,5,7H2,(H,18,19)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 33n/an/an/an/an/an/a



Amgen, Inc.

Curated by ChEMBL


Assay Description
Inhibition of human PHD2 assesssed as hydroxylation of Pro564 in human HIF-1alpha by TR-FRET assay

Bioorg Med Chem Lett 18: 3925-8 (2008)


Article DOI: 10.1016/j.bmcl.2008.06.031
BindingDB Entry DOI: 10.7270/Q2XW4JM5
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM93422
PNG
(PHD Inhibitor, 12{1,1,2})
Show SMILES CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C38H37N5O8/c1-22(44)41-30(19-24-12-14-26-10-6-7-11-27(26)16-24)36(49)42-29(18-23-8-4-3-5-9-23)35(48)39-20-25-13-15-31-28(17-25)34(47)33(38(51)43(31)2)37(50)40-21-32(45)46/h3-17,29-30,47H,18-21H2,1-2H3,(H,39,48)(H,40,50)(H,41,44)(H,42,49)(H,45,46)/t29-,30-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 35n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM93423
PNG
(PHD Inhibitor, 12{2,3,2} | PHD Inhibitor, 12{2,4,2...)
Show SMILES CC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C34H35N5O8/c1-20(40)37-26(17-22-11-7-4-8-12-22)32(45)38-25(16-21-9-5-3-6-10-21)31(44)35-18-23-13-14-27-24(15-23)30(43)29(34(47)39(27)2)33(46)36-19-28(41)42/h3-15,25-26,43H,16-19H2,1-2H3,(H,35,44)(H,36,46)(H,37,40)(H,38,45)(H,41,42)/t25-,26-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 37.4n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM93419
PNG
(PHD Inhibitor, 12{2,4,1})
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)c3ccccc3)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C39H37N5O8/c1-44-31-18-17-26(19-28(31)34(47)33(39(44)52)38(51)41-23-32(45)46)22-40-36(49)29(20-24-11-5-2-6-12-24)43-37(50)30(21-25-13-7-3-8-14-25)42-35(48)27-15-9-4-10-16-27/h2-19,29-30,47H,20-23H2,1H3,(H,40,49)(H,41,51)(H,42,48)(H,43,50)(H,45,46)/t29-,30-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 38.3n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93418
PNG
(PHD Inhibitor, 12{2,3,1})
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)C[C@H](Cc3ccccc3)NC(=O)c3ccccc3)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C40H39N5O8/c1-45-32-18-17-27(20-30(32)36(49)35(40(45)53)39(52)42-24-34(47)48)23-41-38(51)31(21-26-13-7-3-8-14-26)44-33(46)22-29(19-25-11-5-2-6-12-25)43-37(50)28-15-9-4-10-16-28/h2-18,20,29,31,49H,19,21-24H2,1H3,(H,41,51)(H,42,52)(H,43,50)(H,44,46)(H,47,48)/t29-,31+/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 40n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM93425
PNG
(PHD Inhibitor, 12{4,1,2})
Show SMILES CC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)NCC(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C31H31N5O8/c1-17(37)35-23(13-18-7-9-20-5-3-4-6-21(20)11-18)29(42)33-15-25(38)32-14-19-8-10-24-22(12-19)28(41)27(31(44)36(24)2)30(43)34-16-26(39)40/h3-12,23,41H,13-16H2,1-2H3,(H,32,38)(H,33,42)(H,34,43)(H,35,37)(H,39,40)/t23-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 41.9n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM93426
PNG
(PHD Inhibitor, 12{2,5,2})
Show SMILES CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C34H35N5O8/c1-20(40)37-26(17-22-11-7-4-8-12-22)32(45)38-25(16-21-9-5-3-6-10-21)31(44)35-18-23-13-14-27-24(15-23)30(43)29(34(47)39(27)2)33(46)36-19-28(41)42/h3-15,25-26,43H,16-19H2,1-2H3,(H,35,44)(H,36,46)(H,37,40)(H,38,45)(H,41,42)/t25-,26+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 44.8n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93418
PNG
(PHD Inhibitor, 12{2,3,1})
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)C[C@H](Cc3ccccc3)NC(=O)c3ccccc3)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C40H39N5O8/c1-45-32-18-17-27(20-30(32)36(49)35(40(45)53)39(52)42-24-34(47)48)23-41-38(51)31(21-26-13-7-3-8-14-26)44-33(46)22-29(19-25-11-5-2-6-12-25)43-37(50)28-15-9-4-10-16-28/h2-18,20,29,31,49H,19,21-24H2,1H3,(H,41,51)(H,42,52)(H,43,50)(H,44,46)(H,47,48)/t29-,31+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 49n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM50252001
PNG
(2-(3-hydroxy-2-(2-tosylacetamido)-2,3-dihydrothiaz...)
Show SMILES Cc1ccc(cc1)S(=O)(=O)CC(=O)N=c1scc(CC(O)=O)n1O |w:13.13|
Show InChI InChI=1S/C14H14N2O6S2/c1-9-2-4-11(5-3-9)24(21,22)8-12(17)15-14-16(20)10(7-23-14)6-13(18)19/h2-5,7,20H,6,8H2,1H3,(H,18,19)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 50n/an/an/an/an/an/a



Amgen, Inc.

Curated by ChEMBL


Assay Description
Inhibition of human PHD2 assesssed as hydroxylation of Pro564 in human HIF-1alpha by TR-FRET assay

Bioorg Med Chem Lett 18: 3925-8 (2008)


Article DOI: 10.1016/j.bmcl.2008.06.031
BindingDB Entry DOI: 10.7270/Q2XW4JM5
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN2


(Homo sapiens (Human))		BDBM93433
PNG
(PHD Inhibitor, 12{2,1,4})
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc4ccccc4c3)NC(=O)C(C)(C)C)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C41H43N5O8/c1-41(2,3)40(54)45-31(21-25-14-16-27-12-8-9-13-28(27)18-25)37(51)44-30(20-24-10-6-5-7-11-24)36(50)42-22-26-15-17-32-29(19-26)35(49)34(39(53)46(32)4)38(52)43-23-33(47)48/h5-19,30-31,49H,20-23H2,1-4H3,(H,42,50)(H,43,52)(H,44,51)(H,45,54)(H,47,48)/t30-,31-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 60.8n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM50264219
PNG
(2-(6-chloro-1-phenyl-1H-imidazo[4,5-c]pyridine-4-c...)
Show SMILES OC(=O)CNC(=O)c1nc(Cl)cc2n(cnc12)-c1ccccc1
Show InChI InChI=1S/C15H11ClN4O3/c16-11-6-10-13(14(19-11)15(23)17-7-12(21)22)18-8-20(10)9-4-2-1-3-5-9/h1-6,8H,7H2,(H,17,23)(H,21,22)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 66n/an/an/an/an/an/a



Amgen, Inc.

Curated by ChEMBL


Assay Description
Inhibition of PHD2 (unknown origin) by fluorescence energy transfer analysis

Bioorg Med Chem Lett 18: 5023-6 (2008)


Article DOI: 10.1016/j.bmcl.2008.08.012
BindingDB Entry DOI: 10.7270/Q2ZS2WB7
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM93427
PNG
(PHD Inhibitor, 12{2,6,2})
Show SMILES CC(C)C[C@H](NC(C)=O)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C31H37N5O8/c1-17(2)12-22(34-18(3)37)29(42)35-23(14-19-8-6-5-7-9-19)28(41)32-15-20-10-11-24-21(13-20)27(40)26(31(44)36(24)4)30(43)33-16-25(38)39/h5-11,13,17,22-23,40H,12,14-16H2,1-4H3,(H,32,41)(H,33,43)(H,34,37)(H,35,42)(H,38,39)/t22-,23+/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 67.5n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM50251900
PNG
(2-(3-hydroxy-2-(2-(phenylsulfonyl)acetamido)-2,3-d...)
Show SMILES OC(=O)Cc1csc(=NC(=O)CS(=O)(=O)c2ccccc2)n1O |w:8.8|
Show InChI InChI=1S/C13H12N2O6S2/c16-11(8-23(20,21)10-4-2-1-3-5-10)14-13-15(19)9(7-22-13)6-12(17)18/h1-5,7,19H,6,8H2,(H,17,18)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 72n/an/an/an/an/an/a



Amgen, Inc.

Curated by ChEMBL


Assay Description
Inhibition of human PHD2 assesssed as hydroxylation of Pro564 in human HIF-1alpha by TR-FRET assay

Bioorg Med Chem Lett 18: 3925-8 (2008)


Article DOI: 10.1016/j.bmcl.2008.06.031
BindingDB Entry DOI: 10.7270/Q2XW4JM5
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM50251905
PNG
(2-(2-(2-(2-chlorophenylsulfonyl)acetamido)-3-hydro...)
Show SMILES OC(=O)Cc1csc(=NC(=O)CS(=O)(=O)c2ccccc2Cl)n1O |w:8.8|
Show InChI InChI=1S/C13H11ClN2O6S2/c14-9-3-1-2-4-10(9)24(21,22)7-11(17)15-13-16(20)8(6-23-13)5-12(18)19/h1-4,6,20H,5,7H2,(H,18,19)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 72n/an/an/an/an/an/a



Amgen, Inc.

Curated by ChEMBL


Assay Description
Inhibition of human PHD2 assesssed as hydroxylation of Pro564 in human HIF-1alpha by TR-FRET assay

Bioorg Med Chem Lett 18: 3925-8 (2008)


Article DOI: 10.1016/j.bmcl.2008.06.031
BindingDB Entry DOI: 10.7270/Q2XW4JM5
More data for this
Ligand-Target Pair
Prolyl hydroxylase EGLN3


(Homo sapiens (Human))		BDBM93420
PNG
(PHD Inhibitor, 12{3,1,4})
Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1cccc2ccccc12)NC(=O)C(C)(C)C)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C38H45N5O8/c1-21(2)16-27(41-34(48)28(42-37(51)38(3,4)5)18-24-12-9-11-23-10-7-8-13-25(23)24)33(47)39-19-22-14-15-29-26(17-22)32(46)31(36(50)43(29)6)35(49)40-20-30(44)45/h7-15,17,21,27-28,46H,16,18-20H2,1-6H3,(H,39,47)(H,40,49)(H,41,48)(H,42,51)(H,44,45)/t27-,28-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 77n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM93428
PNG
(PHD Inhibitor, 12{2,3,4} | PHD Inhibitor, 12{2,4,4...)
Show SMILES Cn1c2ccc(CNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)C(C)(C)C)cc2c(O)c(C(=O)NCC(O)=O)c1=O |r|
Show InChI InChI=1S/C37H41N5O8/c1-37(2,3)36(50)41-27(19-23-13-9-6-10-14-23)33(47)40-26(18-22-11-7-5-8-12-22)32(46)38-20-24-15-16-28-25(17-24)31(45)30(35(49)42(28)4)34(48)39-21-29(43)44/h5-17,26-27,45H,18-21H2,1-4H3,(H,38,46)(H,39,48)(H,40,47)(H,41,50)(H,43,44)/t26-,27-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 86.4n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM93423
PNG
(PHD Inhibitor, 12{2,3,2} | PHD Inhibitor, 12{2,4,2...)
Show SMILES CC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C34H35N5O8/c1-20(40)37-26(17-22-11-7-4-8-12-22)32(45)38-25(16-21-9-5-3-6-10-21)31(44)35-18-23-13-14-27-24(15-23)30(43)29(34(47)39(27)2)33(46)36-19-28(41)42/h3-15,25-26,43H,16-19H2,1-2H3,(H,35,44)(H,36,46)(H,37,40)(H,38,45)(H,41,42)/t25-,26-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 90.2n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Egl nine homolog 1


(Homo sapiens (Human))		BDBM93430
PNG
(PHD Inhibitor, 12{2,1,2})
Show SMILES CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccccc1)C(=O)NCc1ccc2n(C)c(=O)c(C(=O)NCC(O)=O)c(O)c2c1 |r|
Show InChI InChI=1S/C38H37N5O8/c1-22(44)41-30(19-24-12-14-26-10-6-7-11-27(26)16-24)36(49)42-29(18-23-8-4-3-5-9-23)35(48)39-20-25-13-15-31-28(17-25)34(47)33(38(51)43(31)2)37(50)40-21-32(45)46/h3-17,29-30,47H,18-21H2,1-2H3,(H,39,48)(H,40,50)(H,41,44)(H,42,49)(H,45,46)/t29-,30-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 93.8n/an/an/an/an/an/a



Amgen, Inc.



Assay Description
PHD1,2,3 activity was measured utilizing homogeneous time-resolved fluroescence energy transfer techology by detecting the trans-4-hydroxylatio of HI...

J Comb Chem 12: 676-86 (2010)


Article DOI: 10.1021/cc100073a
BindingDB Entry DOI: 10.7270/Q2B27SXP
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 91 total )  |  Next  |  Last  >>
Jump to: